J 2021

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

BOSSI, P., A. T. CHAN, L. LICITRA, A. TRAMA, E. ORLANDI et. al.

Basic information

Original name

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Authors

BOSSI, P. (guarantor), A. T. CHAN, L. LICITRA, A. TRAMA, E. ORLANDI, E. P. HUI, Jana HALÁMKOVÁ (203 Czech Republic, belonging to the institution), S. MATTHEIS, B. BAUJAT, J. HARDILLO, L. SMEELE, C. VAN HERPEN, A. CASTRO and J. P. MACHIELS

Edition

Annals of Oncology, AMSTERDAM, Oxford University Press, 2021, 0923-7534

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 51.769

RIV identification code

RIV/00216224:14110/21:00122115

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/j.annonc.2020.12.007

UT WoS

000629502100007

Keywords in English

nasopharyngeal cancer; Clinical Practice Guidelines; diagnosis; treatment; follow-up

Tags

14110811, Excelence Science, MOÚ, RIV, rivok, user

Tags

International impact, Reviewed
Změněno: 17/3/2022 12:40, Mgr. Tereza Miškechová

Abstract

V originále

This ESMO-EURACAN Clinical Practice Guideline provides key recommendations for managing nasopharyngeal cancer (NPC). It covers screening, clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up. Treatment algorithms for locoregional and recurrent/metastatic NPC are provided. Recommendations were compiled by the authors based on available scientific data and the authors' collective expert opinion.

Links

LM2018128, research and development project
Name: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Acronym: CZECRIN)
Investor: Ministry of Education, Youth and Sports of the CR
Displayed: 1/11/2024 06:57